Literature DB >> 31740593

Proof of concept for identifying cystic fibrosis from perspiration samples.

Zhenpeng Zhou1, Daniel Alvarez2, Carlos Milla2, Richard N Zare3.   

Abstract

The gold standard for cystic fibrosis (CF) diagnosis is the determination of chloride concentration in sweat. Current testing methodology takes up to 3 h to complete and has recognized shortcomings on its diagnostic accuracy. We present an alternative method for the identification of CF by combining desorption electrospray ionization mass spectrometry and a machine-learning algorithm based on gradient boosted decision trees to analyze perspiration samples. This process takes as little as 2 min, and we determined its accuracy to be 98 ± 2% by cross-validation on analyzing 277 perspiration samples. With the introduction of statistical bootstrap, our method can provide a confidence estimate of our prediction, which helps diagnosis decision-making. We also identified important peaks by the feature selection algorithm and assigned the chemical structure of the metabolites by high-resolution and/or tandem mass spectrometry. We inspected the correlation between mild and severe CFTR gene mutation types and lipid profiles, suggesting a possible way to realize personalized medicine with this noninvasive, fast, and accurate method.

Entities:  

Keywords:  cystic fibrosis; desorption electrospray ionization; machine learning; mass spectrometry

Mesh:

Substances:

Year:  2019        PMID: 31740593      PMCID: PMC6900510          DOI: 10.1073/pnas.1909630116

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  38 in total

Review 1.  Potential impact of newborn screening for cystic fibrosis on child survival: a systematic review and analysis.

Authors:  Scott D Grosse; Margaret Rosenfeld; Owen J Devine; Huichuan J Lai; Philip M Farrell
Journal:  J Pediatr       Date:  2006-09       Impact factor: 4.406

2.  Gastrointestinal handling of [1-13C]palmitic acid in healthy controls and patients with cystic fibrosis.

Authors:  J L Murphy; A E Jones; M Stolinski; S A Wootton
Journal:  Arch Dis Child       Date:  1997-05       Impact factor: 3.791

3.  Evaluation of a cystic fibrosis screening system incorporating a miniature sweat stimulator and disposable chloride sensor.

Authors:  W J Warwick; N N Huang; W W Waring; A G Cherian; I Brown; E Stejskal-Lorenz; W H Yeung; G Duhon; J G Hill; D Strominger
Journal:  Clin Chem       Date:  1986-05       Impact factor: 8.327

4.  Sweat conductivity: an accurate diagnostic test for cystic fibrosis?

Authors:  Ana Claudia Veras Mattar; Claudio Leone; Joaquim Carlos Rodrigues; Fabíola Villac Adde
Journal:  J Cyst Fibros       Date:  2014-01-31       Impact factor: 5.482

5.  Abnormal lipid concentrations in cystic fibrosis.

Authors:  Veronica Figueroa; Carlos Milla; Elizabeth J Parks; Sarah Jane Schwarzenberg; Antoinette Moran
Journal:  Am J Clin Nutr       Date:  2002-06       Impact factor: 7.045

6.  The need for quality improvement in sweat testing infants after newborn screening for cystic fibrosis.

Authors:  Vicky A Legrys; Susanna A McColley; Zhanhai Li; Philip M Farrell
Journal:  J Pediatr       Date:  2010-09-16       Impact factor: 4.406

7.  Metabolomic profiling of regulatory lipid mediators in sputum from adult cystic fibrosis patients.

Authors:  Jun Yang; Jason P Eiserich; Carroll E Cross; Brian M Morrissey; Bruce D Hammock
Journal:  Free Radic Biol Med       Date:  2012-05-08       Impact factor: 7.376

8.  β-adrenergic sweat secretion as a diagnostic test for cystic fibrosis.

Authors:  Paul Quinton; Laura Molyneux; Wan Ip; Annie Dupuis; Julie Avolio; Elizabeth Tullis; Douglas Conrad; A K Shamsuddin; Peter Durie; Tanja Gonska
Journal:  Am J Respir Crit Care Med       Date:  2012-08-02       Impact factor: 21.405

Review 9.  Abnormal unsaturated fatty acid metabolism in cystic fibrosis: biochemical mechanisms and clinical implications.

Authors:  Adam C Seegmiller
Journal:  Int J Mol Sci       Date:  2014-09-11       Impact factor: 5.923

10.  Skin Biomarkers for Cystic Fibrosis: A Potential Non-Invasive Approach for Patient Screening.

Authors:  Cibele Zanardi Esteves; Letícia de Aguiar Dias; Estela de Oliveira Lima; Diogo Noin de Oliveira; Carlos Fernando Odir Rodrigues Melo; Jeany Delafiori; Carla Cristina Souza Gomez; José Dirceu Ribeiro; Antônio Fernando Ribeiro; Carlos Emílio Levy; Rodrigo Ramos Catharino
Journal:  Front Pediatr       Date:  2018-01-10       Impact factor: 3.418

View more
  5 in total

1.  Single-Cell Classification Using Mass Spectrometry through Interpretable Machine Learning.

Authors:  Yuxuan Richard Xie; Daniel C Castro; Sara E Bell; Stanislav S Rubakhin; Jonathan V Sweedler
Journal:  Anal Chem       Date:  2020-06-25       Impact factor: 6.986

2.  Cell-morphodynamic phenotype classification with application to cancer metastasis using cell magnetorotation and machine-learning.

Authors:  Remy Elbez; Jeff Folz; Alan McLean; Hernan Roca; Joseph M Labuz; Kenneth J Pienta; Shuichi Takayama; Raoul Kopelman
Journal:  PLoS One       Date:  2021-11-17       Impact factor: 3.240

Review 3.  Artificial Intelligence Techniques to Predict the Airway Disorders Illness: A Systematic Review.

Authors:  Apeksha Koul; Rajesh K Bawa; Yogesh Kumar
Journal:  Arch Comput Methods Eng       Date:  2022-09-28       Impact factor: 8.171

4.  Metabo-tip: a metabolomics platform for lifestyle monitoring supporting the development of novel strategies in predictive, preventive and personalised medicine.

Authors:  Julia Brunmair; Andrea Bileck; Thomas Stimpfl; Florian Raible; Giorgia Del Favero; Samuel M Meier-Menches; Christopher Gerner
Journal:  EPMA J       Date:  2021-05-04       Impact factor: 6.543

Review 5.  Proteomics and Metabolomics for Cystic Fibrosis Research.

Authors:  Nara Liessi; Nicoletta Pedemonte; Andrea Armirotti; Clarissa Braccia
Journal:  Int J Mol Sci       Date:  2020-07-30       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.